These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8463546

  • 21. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
    Gilad S, Chayen R, Tordjman K, Kisch E, Stern N.
    Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
    [Abstract] [Full Text] [Related]

  • 22. Steroid secretory characteristics of a virilizing adrenal adenoma in a woman.
    Bradshaw KD, Milewich L, Mason JI, Parker CR, MacDonald PC, Carr BR.
    J Endocrinol; 1994 Feb; 140(2):297-307. PubMed ID: 8169562
    [Abstract] [Full Text] [Related]

  • 23. Plasma levels of steroid glucuronides in prepubertal, adult and elderly men.
    Bélanger A, Brochu M, Cliche J.
    J Steroid Biochem; 1986 May; 24(5):1069-72. PubMed ID: 2941624
    [Abstract] [Full Text] [Related]

  • 24. Gemfibrozil treatment is associated with elevated adrenal androgen, androstanediol glucuronide and cortisol levels in dyslipidemic men.
    Hautanen A, Mänttäri M, Manninen V, Adlercreutz H.
    J Steroid Biochem Mol Biol; 1994 Dec; 51(5-6):307-13. PubMed ID: 7826893
    [Abstract] [Full Text] [Related]

  • 25. Serum androsterone conjugates differentiate between acne and hirsutism in hyperandrogenic women.
    Carmina E, Stanczyk FZ, Matteri RK, Lobo RA.
    Fertil Steril; 1991 May; 55(5):872-6. PubMed ID: 1827073
    [Abstract] [Full Text] [Related]

  • 26. Female androgenic alopecia. The 3 alpha,17 beta-androstanediol glucuronide/sex hormone binding globulin ratio as a possible marker for female pattern baldness.
    De Villez RL, Dunn J.
    Arch Dermatol; 1986 Sep; 122(9):1011-5. PubMed ID: 2943232
    [Abstract] [Full Text] [Related]

  • 27. Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly men.
    Morimoto I, Edmiston A, Hawks D, Horton R.
    J Clin Endocrinol Metab; 1981 Apr; 52(4):772-8. PubMed ID: 7204542
    [Abstract] [Full Text] [Related]

  • 28. Increased 5 alpha-reductase activity in idiopathic hirsutism.
    Serafini P, Lobo RA.
    Fertil Steril; 1985 Jan; 43(1):74-8. PubMed ID: 3155511
    [Abstract] [Full Text] [Related]

  • 29. Isolated precocious pubarche: an approach.
    Balducci R, Boscherini B, Mangiantini A, Morellini M, Toscano V.
    J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
    [Abstract] [Full Text] [Related]

  • 30. Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A.
    Vexiau P, Fiet J, Boudou P, Villette JM, Feutren G, Hardy N, Julien R, Dreux C, Bach JF, Cathelineau G.
    J Steroid Biochem; 1990 Jan; 35(1):133-7. PubMed ID: 2137888
    [Abstract] [Full Text] [Related]

  • 31. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
    Montalto J, Whorwood CB, Funder JW, Yong AB, Callan A, Davies HE, Connelly JF.
    Clin Endocrinol (Oxf); 1990 Jan; 32(1):1-12. PubMed ID: 2139595
    [Abstract] [Full Text] [Related]

  • 32. Plasma levels of C-19 steroids and 5 alpha-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women.
    Brochu M, Bélanger A, Tremblay RR.
    Fertil Steril; 1987 Dec; 48(6):948-53. PubMed ID: 2960564
    [Abstract] [Full Text] [Related]

  • 33. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
    [Abstract] [Full Text] [Related]

  • 34. Effects of gemfibrozil treatment on serum levels of androstanediol glucuronide and adrenal androgens.
    Hautanen A, Mänttäri M, Manninen V, Frick MH, Adlercreutz H.
    J Steroid Biochem Mol Biol; 1992 May; 42(3-4):433-4. PubMed ID: 1534991
    [Abstract] [Full Text] [Related]

  • 35. Correlation of serum 3 alpha-androstanediol glucuronide with acne and chest hair density in men.
    Lookingbill DP, Egan N, Santen RJ, Demers LM.
    J Clin Endocrinol Metab; 1988 Nov; 67(5):986-91. PubMed ID: 2972739
    [Abstract] [Full Text] [Related]

  • 36. Is 3 alpha, 17 beta-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations?
    Vogt C, Dericks-Tan JS, Kuhl H, Taubert HD.
    Gynecol Endocrinol; 1992 Jun; 6(2):85-90. PubMed ID: 1386956
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Serum levels of 5-androstene-3 beta,17 beta-diol sulphate, 5 alpha-androstane-3 alpha, 17beta-diol sulphate and glucuronide, in late onset 21-hydroxylase deficiency.
    Montalto J, Funder JW, Yong AB, Whorwood CB, Connelly JF.
    J Steroid Biochem Mol Biol; 1990 Nov 30; 37(4):593-8. PubMed ID: 2177625
    [Abstract] [Full Text] [Related]

  • 39. Effect of MK-906, a specific 5 alpha-reductase inhibitor, on serum androgens and androgen conjugates in normal men.
    Rittmaster RS, Stoner E, Thompson DL, Nance D, Lasseter KC.
    J Androl; 1989 Nov 30; 10(4):259-62. PubMed ID: 2550402
    [Abstract] [Full Text] [Related]

  • 40. Serum C-19 steroid sulphates in females with clinical hyperandrogenism.
    Montalo J, Funder JW, Yong AB, Callan A, Davies HE, Connelly JF.
    J Steroid Biochem; 1989 Nov 30; 34(1-6):531-4. PubMed ID: 2533951
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.